GRISACTIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Grisactin, and when can generic versions of Grisactin launch?
Grisactin is a drug marketed by Wyeth Ayerst and is included in four NDAs.
The generic ingredient in GRISACTIN is griseofulvin, ultramicrocrystalline. There is one drug master file entry for this compound. Additional details are available on the griseofulvin, ultramicrocrystalline profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GRISACTIN?
- What are the global sales for GRISACTIN?
- What is Average Wholesale Price for GRISACTIN?
Summary for GRISACTIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 96 |
| Patent Applications: | 3,977 |
| DailyMed Link: | GRISACTIN at DailyMed |
US Patents and Regulatory Information for GRISACTIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Ayerst | GRISACTIN | griseofulvin, microcrystalline | CAPSULE;ORAL | 050051-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wyeth Ayerst | GRISACTIN ULTRA | griseofulvin, ultramicrocrystalline | TABLET;ORAL | 062438-002 | Nov 17, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wyeth Ayerst | GRISACTIN ULTRA | griseofulvin, ultramicrocrystalline | TABLET;ORAL | 062178-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wyeth Ayerst | GRISACTIN | griseofulvin, microcrystalline | CAPSULE;ORAL | 050051-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wyeth Ayerst | GRISACTIN | griseofulvin, microcrystalline | TABLET;ORAL | 060212-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
